BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16416184)

  • 1. Development of primary biliary cirrhosis in a patient with Crohn's disease: a case report and review of the literature.
    Jang HJ; Kim GS; Eun CS; Kae SH; Jang WY; Lee J
    Dig Dis Sci; 2005 Dec; 50(12):2335-7. PubMed ID: 16416184
    [No Abstract]   [Full Text] [Related]  

  • 2. Late presentation of a biliary tract complication after right hepatic donation resulting in secondary biliary cirrhosis.
    Morelli G; Reed A; Firpi RJ; Machicao V; Abdelmalek MF; Soldevilla-Pico C; Nelson DR
    Liver Transpl; 2006 Feb; 12(2):306-9. PubMed ID: 16447188
    [No Abstract]   [Full Text] [Related]  

  • 3. Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: a paradoxical effect.
    Kotze PG; de Barcelos IF; da Silva Kotze LM
    J Crohns Colitis; 2013 Dec; 7(11):e599-600. PubMed ID: 23849401
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of primary biliary cirrhosis with ursodeoxycholic acid without liver biopsy?].
    Siboni AH
    Ugeskr Laeger; 2004 Aug; 166(32):2688; author reply 2688. PubMed ID: 15347178
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of primary biliary cirrhosis with ursodeoxycholic acid].
    Lotterer E; Fleig WE
    Z Gastroenterol; 1993 Oct; 31(10):633-5. PubMed ID: 8256481
    [No Abstract]   [Full Text] [Related]  

  • 6. Gallbladder carcinoma complicating Crohn's disease.
    Ogawa H; Funayama Y; Naito H; Fukushima K; Shibata C; Matsuno S; Sasaki I
    Am J Gastroenterol; 2001 Jan; 96(1):263-4. PubMed ID: 11197277
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bronchiolitis obliterans with organizing pneumonia and primary biliary cirrhosis].
    Montero C; Brage A; Rodríguez-Trigo G; Verea H
    Med Clin (Barc); 2003 Jan; 120(1):37-8. PubMed ID: 12525305
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia.
    El-Husseini R; Kaplan MM
    Am J Gastroenterol; 2004 Sep; 99(9):1859-60. PubMed ID: 15330929
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of primary biliary cirrhosis with ursodeoxycholic acid].
    Nikolovska D; Vasilev P; Mikhova A
    Vutr Boles; 2000; 32(1):25-7. PubMed ID: 11195193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid.
    Renou C; Bourlière M; Martini F; Ouzan D; Penaranda G; Larroque O; Harafa A; Igual JP; Calvet B; Sokolowsky S; Benderitter T; Halfon P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):781-2. PubMed ID: 16677173
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.
    Abbas G; Lindor KD
    Expert Opin Pharmacother; 2010 Feb; 11(3):387-92. PubMed ID: 20102304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case in point. Primary biliary cirrhosis.
    Jones JW; Ansari A
    Hosp Pract (1995); 1996 Jun; 31(6):173. PubMed ID: 8675541
    [No Abstract]   [Full Text] [Related]  

  • 16. Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis.
    Wouters RS; Bos LP; Engels LG
    Neth J Med; 1990 Aug; 37(1-2):21-3. PubMed ID: 2215828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines.
    Tsochatzis EA; Gurusamy KS; Gluud C; Burroughs AK
    J Hepatol; 2009 Dec; 51(6):1084-5; author reply 1085-6. PubMed ID: 19864037
    [No Abstract]   [Full Text] [Related]  

  • 18. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary biliary cirrhosis. Immunological aggression and aggression by biliary acids].
    Poupon R
    Rev Prat; 1994 May; 44(10):1325-8. PubMed ID: 7939192
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.